x

Posted 13 September, 2022

Nu-Med Plus, Inc. appointed Mr. William Hayde as new CEO

OTC:NUMD appointed new Chief Executive Officer Mr. William Hayde in a 8-K filed on 13 September, 2022.


  The Corporation has appointed Mr. William Hayde as the President, Chief Executive Officer, Director and Chairman of the Board.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Nu-Med Plus, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. It offers hospital, portable, clinical, and commercial units. The company was founded on October 19, 2011 and is headquartered in Jefferson, NY.
Market Cap
$785K
View Company Details
Nu-Med Plus, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On September 12, 2022, Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board and Dr. Brett J. Earl resigned as a director. None of these individuals had any disputes with the Company.


The Corporation has appointed Mr. William Hayde as the President, Chief Executive Officer, Director and Chairman of the Board. Mr. Hayde has been granted an Employment Agreement with the Company. The Company has also authorized the issuance of 2,000,000 shares of restricted common stock be issued to "The Hayde Family Revocable Trust." These shares were part of an agreement with Waterside Capital Advisors, Inc. and 250,000 shares were authorized to be issued at the end of each quarter for services. These shares represent eight consecutive quarters of services and are due and issuable.


The Corporation has also entered into a new Employment Agreement with Mr. Keith L. Merrell, who serves as the Corporations Chief Financial Officer, this Agreement will replace the previous agreement entered into on January 31, 2018.


2